Toll-like receptor 4 is involved in inflammatory and joint destructive pathways in collagen-induced arthritis in DBA1j mice

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Pierer, Matthias ^a   Wagner, Ulf ^a   Rossol, Manuela ^a   Ibrahim, Saleh ^b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; TOLL LIKE RECEPTOR 4; AUTOANTIBODY; CYCLIC CITRULLINATED PEPTIDE; CYCLOPEPTIDE; INTERLEUKIN 10; INTERLEUKIN 12; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DBA 1 MOUSE; DISEASE COURSE; DISEASE SEVERITY; INFLAMMATORY INFILTRATE; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PROTEIN FUNCTION; RHEUMATOID ARTHRITIS; T LYMPHOCYTE ACTIVATION; WILD TYPE; ANIMAL; ARTHRITIS; C3H MOUSE; CELL PROLIFERATION; DBA MOUSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENETICS; HUMAN; IMMUNOLOGY; INFLAMMATION; JOINT; MALE; METABOLISM; MOUSE MUTANT; T LYMPHOCYTE;

MUS;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; CELL PROLIFERATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-17; JOINTS; MALE; MICE; MICE, INBRED C3H; MICE, INBRED DBA; MICE, KNOCKOUT; PEPTIDES, CYCLIC; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80051755778     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023539     Document Type: Article

References (20)

1. Nam JL, Winthrop KL, van Vollenhoven RF, Pavelka K, Valesini G, et al. (2010) Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA. Ann Rheum Dis 69: 976-986.
2. Pasare C, Medzhitov R, (2005) Toll-like receptors: linking innate and adaptive immunity. Adv Exp Med Biol 560: 11-18.
3. Yoshitomi H, Sakaguchi N, Kobayashi K, Brown GD, Tagami T, et al. (2005) A role for fungal { beta}-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice. J Exp Med 201: 949-960.
4. Abdollahi-Roodsaz S, Joosten LA, Roelofs MF, Radstake TR, Matera G, et al. (2007) Inhibition of Toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis. Arthritis Rheum 56: 2957-2967.
5. Abdollahi-Roodsaz S, Joosten LA, Koenders MI, Devesa I, Roelofs MF, et al. (2008) Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis. J Clin Invest 118: 205-216.
6. Joosten LA, Koenders MI, Smeets RL, Heuvelmans-Jacobs M, Helsen MM, et al. (2003) Toll-like receptor 2 pathway drives streptococcal cell wall-induced joint inflammation: critical role of myeloid differentiation factor 88. J Immunol 171: 6145-6153.
7. Seibl R, Birchler T, Loeliger S, Hossle JP, Gay RE, et al. (2003) Expression and regulation of Toll-like receptor 2 in rheumatoid arthritis synovium. Am J Pathol 162: 1221-1227.
8. Pierer M, Rethage J, Seibl R, Lauener R, Brentano F, et al. (2004) Chemokine secretion of rheumatoid arthritis synovial fibroblasts stimulated by Toll-like receptor 2 ligands. J Immunol 172: 1256-1265.
9. Vanags D, Williams B, Johnson B, Hall S, Nash P, et al. (2006) Therapeutic efficacy and safety of chaperonin 10 in patients with rheumatoid arthritis: a double-blind randomised trial. Lancet 368: 855-863.
10. Roelofs MF, Boelens WC, Joosten LA, Abdollahi-Roodsaz S, Geurts J, et al. (2006) Identification of small heat shock protein B8 (HSP22) as a novel TLR4 ligand and potential involvement in the pathogenesis of rheumatoid arthritis. J Immunol 176: 7021-7027.
11. Midwood K, Sacre S, Piccinini AM, Inglis J, Trebaul A, et al. (2009) Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat Med 15: 774-780.
12. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, et al. (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085-2088.
13. Billiau A, Matthys P, (2001) Modes of action of Freund' s adjuvants in experimental models of autoimmune diseases. J Leukoc Biol 70: 849-860.
14. Kuhn KA, Kulik L, Tomooka B, Braschler KJ, Arend WP, et al. (2006) Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J Clin Invest 116: 961-973.
15. Leipe J, Grunke M, Dechant C, Reindl C, Kerzendorf U, et al. (2010) Role of Th17 cells in human autoimmune arthritis. Arthritis Rheum 62: 2876-2885.
16. Nemazee D, Gavin A, Hoebe K, Beutler B, (2006) Immunology: Toll-like receptors and antibody responses. Nature 441: E4; discussion E4.
17. Palm NW, Medzhitov R, (2009) Immunostimulatory activity of haptenated proteins. Proc Natl Acad Sci U S A 106: 4782-4787.
18. Reynolds JM, Pappu BP, Peng J, Martinez GJ, Zhang Y, et al. (2010) Toll-like Receptor 2 Signaling in CD4(+) T Lymphocytes Promotes T Helper 17 Responses and Regulates the Pathogenesis of Autoimmune Disease. Immunity 32: 692-702.
19. van de Veerdonk FL, Teirlinck AC, Kleinnijenhuis J, Kullberg BJ, van Crevel R, et al. (2010) Mycobacterium tuberculosis induces IL-17A responses through TLR4 and dectin-1 and is critically dependent on endogenous IL-1. J Leukoc Biol 88: 227-232.
20. Choe JY, Crain B, Wu SR, Corr M, (2003) Interleukin 1 receptor dependence of serum transferred arthritis can be circumvented by toll-like receptor 4 signaling. J Exp Med 197: 537-542.